According to the official website of the drug clinical trial registration and information disclosure platform, Eli Lilly has registered a phase III clinical study of Brenipatide injections in adults with depression. According to the Insight database, Brenipatide is the world's first GLP-1 product to initiate phase III clinical trials for depression.

Zhitongcaijing · 3d ago
According to the official website of the drug clinical trial registration and information disclosure platform, Eli Lilly has registered a phase III clinical study of Brenipatide injections in adults with depression. According to the Insight database, Brenipatide is the world's first GLP-1 product to initiate phase III clinical trials for depression.